Status:
ENROLLING_BY_INVITATION
Neurological Development In Toddlers After Maternal SARS-CoV-2 Infection During Pregnancy
Lead Sponsor:
Philipps University Marburg
Conditions:
SARS CoV-2
Developmental Disorder
Eligibility:
All Genders
3-5 years
Brief Summary
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is a virus that causes neurological symptoms in a significant proportion of patients in addition to respiratory symptoms. Intrauterine...
Detailed Description
In Utero Exposure to SARS-CoV-2 - the CRONOS registry The "COVID-19 Related Obstetric and Neonatal Outcome Study" (CRONOS) investigated the short-term effects of SARS-CoV-2 infections on mothers and t...
Eligibility Criteria
Inclusion
- Toddlers (age 33 to 60 months), who were exposed (case) or not exposed (controll) with SARS-CoV-2 intrauterin.
Exclusion
- No parental consent
Key Trial Info
Start Date :
April 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06968897
Start Date
April 1 2025
End Date
June 30 2026
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Philipps University of Marburg
Marburg, Germany, 35037